Exiqon A/S

Research and Markets Adds Report: Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities.
Health & Beauty Close-Up; 11/4/2009; 695 words; ...Technologies - Silence Therapeutics - Siranoamics, - siRNAsense A/S - Sylentis Pharmaceuticals - Tacere Therapeutics - Targeted...Takeda. RNAi diagnostic companies: - Asuragen Diagnostics - Exiqon Diagnostics - Rosetta Genomics Report information: http...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1636 words; ...appear to contribute to the vaccine's immunogenicity. Bioenvision Inc...right of supply from the Danish company Exiqon A/S to incorporate Locked Nucleic Acid technology into certain of DNAPrint's pharmacogenomics and forensics tests...

Santaris Signs $200M LNA Oncology Pact With Enzon.
BIOWORLD Today; 11/3/2009; 1173 words; ...in 2003 of Vedbaek, Denmark-based Cureon A/S and Copenhagen-based Pantheco A/S, has sole rights to therapeutic applications of LNA. Vedbaek-based Exiqon A/S, the original parent of Cureon, holds rights...

Exiqon Diagnostics Announces Online PortiQo Doctor Portal Online Application Offers a Secure Location for Exiqon Diagnostics to Deliver Test Reports and Content Directly to Oncologists.
Cancer Weekly; 8/18/2009; 1276 words; ...PortiQo Doctor Portal will enhance Exiqon's already strong position in the market...oncologists." To learn more about Exiqon's PortiQo™ system...select an efficacious! treatment. Exiqon's new molecular diagnostic products...

Exiqon Diagnostics Launches New ArQive Patient Registry for Colon, Lung and Ovarian Cancer.
Cancer Weekly; 8/18/2009; 1563 words; ...where the company's technologies provide...diagnostic tests (Exiqon Diagnostics), sale...of each patient's tumor, treatment...for individuals. Exiqon is uniquely positioned...efficacious! treatment. Exiqon's new molecular diagnostic...